TERESA GROSSI: Open Payments
NPI 1700935103 · VALENCIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,774 in 105 payments from 17 companies in 2025. Trend: 2023 $655 · 2024 $996 · 2025 $1,774
Food & beverage: $1,774
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $465 |
| Lilly USA, LLC | 14 | $251 |
| GENZYME CORPORATION | 8 | $245 |
| Novartis Pharmaceuticals Corporation | 13 | $232 |
| Galderma Laboratories, L.P. | 20 | $198 |
| Amgen Inc. | 4 | $75 |
| Organon LLC | 5 | $61 |
| UCB, Inc. | 1 | $39 |
| E.R. Squibb & Sons, L.L.C. | 1 | $31 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $29 |
Products named: SKYRIZI, DUPIXENT, TALTZ, NEMLUVIO, COSENTYX, Rhapsido, RINVOQ, Otezla.
Industry payments across CA — which companies pay providers there.
